Wave Life Sciences (WVE) Revenue & Revenue Breakdown
Wave Life Sciences Revenue Highlights
Latest Revenue (Y)
$113.31M
Latest Revenue (Q)
$19.69M
Wave Life Sciences Revenue by Period
Wave Life Sciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $113.31M | 3005.10% |
2022-12-31 | $3.65M | -91.09% |
2021-12-31 | $40.96M | 104.03% |
2020-12-31 | $20.08M | 25.61% |
2019-12-31 | $15.98M | 10.89% |
2018-12-31 | $14.41M | 289.15% |
2017-12-31 | $3.70M | 149.43% |
2016-12-31 | $1.49M | 876.97% |
2015-12-31 | $152.00K | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | - |
Wave Life Sciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $19.69M | 57.06% |
2024-03-31 | $12.54M | -56.85% |
2023-12-31 | $29.06M | -40.96% |
2023-09-30 | $49.21M | 122.63% |
2023-06-30 | $22.11M | 70.98% |
2023-03-31 | $12.93M | 943.50% |
2022-12-31 | $1.24M | 334.74% |
2022-09-30 | $285.00K | -24.00% |
2022-06-30 | $375.00K | -78.57% |
2022-03-31 | $1.75M | -0.85% |
2021-12-31 | $1.76M | -95.15% |
2021-09-30 | $36.42M | 1212.07% |
2021-06-30 | $2.78M | 100.00% |
2021-03-31 | - | -100.00% |
2020-12-31 | $9.44M | 173.59% |
2020-09-30 | $3.45M | 13.97% |
2020-06-30 | $3.03M | -27.25% |
2020-03-31 | $4.16M | 73.38% |
2019-12-31 | $2.40M | -18.06% |
2019-09-30 | $2.93M | -61.60% |
2019-06-30 | $7.63M | 152.08% |
2019-03-31 | $3.03M | -16.41% |
2018-12-31 | $3.62M | -19.43% |
2018-09-30 | $4.49M | -7.91% |
2018-06-30 | $4.88M | 243.11% |
2018-03-31 | $1.42M | -15.16% |
2017-12-31 | $1.68M | 147.93% |
2017-09-30 | $676.00K | - |
2017-06-30 | $676.00K | - |
2017-03-31 | $676.00K | - |
2016-12-31 | $676.00K | 72.45% |
2016-09-30 | $392.00K | -6.00% |
2016-06-30 | $417.00K | 100.00% |
2016-03-31 | - | -100.00% |
2015-12-31 | $152.00K | 100.00% |
2015-09-30 | - | -100.00% |
2015-06-30 | $126.00K | 384.62% |
2015-03-31 | $26.00K | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | - |
Wave Life Sciences Revenue Breakdown
Wave Life Sciences Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Jun 21 |
---|---|
Research Term | $18.50M |
Latest
Wave Life Sciences Revenue Breakdown by Country
Quarterly Revenue by Country
Country | Jun 21 |
---|---|
Research Term | $18.50M |
Latest
Wave Life Sciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals | $1.83B | $420.15M |
AMLX | Amylyx Pharmaceuticals | $380.79M | $416.00K |
APLS | Apellis Pharmaceuticals | $366.28M | $176.57M |
BPMC | Blueprint Medicines | $249.38M | $128.18M |
WVE | Wave Life Sciences | $113.31M | $19.69M |
CTMX | CytomX Therapeutics | $101.21M | $33.43M |
TCRX | TScan Therapeutics | $21.05M | - |
ITOS | iTeos Therapeutics | $12.60M | $35.00M |
MREO | Mereo BioPharma Group | $10.00M | - |
ASMB | Assembly Biosciences | $7.16M | $6.84M |
PRQR | ProQR Therapeutics | $6.38M | $4.48M |
ARWR | Arrowhead Pharmaceuticals | $3.55M | - |
XFOR | X4 Pharmaceuticals | - | $560.00K |
DAWN | Day One Biopharmaceuticals | - | $20.07M |
ABOS | Acumen Pharmaceuticals | - | - |
INZY | Inozyme Pharma | - | - |
TERN | Terns Pharmaceuticals | - | - |